ARWR : Arrowhead Pharmaceuticals stock forecast, predictions, and share price target 2024 - 2025 - 2030 with analysis
| year | Average | Low | High | Change from close on 2024-09-06 |
|---|---|---|---|---|
| 2024 | $22.42 | $22.38 | $22.51 | 0.91% |
| 2025 | $20.19 | $19.19 | $22.22 | -9.14% |
| 2026 | $20.83 | $19.35 | $22.18 | -6.24% |
| 2027 | $21.14 | $20.06 | $22.19 | -4.88% |
| 2028 | $20.98 | $19.86 | $23.66 | -5.56% |
| 2029 | $20.75 | $15.87 | $23.9 | -6.62% |
| 2030 | $29.0 | $14.33 | $63.89 | 30.53% |
| 2031 | $107.6 | $79.75 | $120.84 | 384.26% |
| 2032 | $71.48 | $40.63 | $105.16 | 221.7% |
| 2033 | $25.57 | $18.36 | $38.03 | 15.08% |
| 2034 | $26.09 | $22.33 | $28.51 | 17.4% |
The 14 Wall Street analysts offering Arrowhead Pharmaceuticals stock forecast in the last 6 months have average price target of
$61.64 with a high forecast of $90.0 and a low forecast of $27.0.
The average Arrowhead Pharmaceuticals stock forecast represents a 177.41%
increase from the last price of $22.2199993133545.
For Arrowhead Pharmaceuticals stock forecast for 2024, 3 predictions are offered for each month of 2024 with average Arrowhead Pharmaceuticals stock
forecast of $22.42, a high forecast of $22.51, and a low forecast of $22.38.
The average Arrowhead Pharmaceuticals stock forecast 2024 represents a 0.91%
increase from the last price of $22.2199993133545.
For Arrowhead Pharmaceuticals stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Arrowhead Pharmaceuticals stock
forecast of $20.19, a high forecast of $22.22, and a low forecast of $19.19.
The average Arrowhead Pharmaceuticals stock forecast 2025 represents a -9.14%
decrease from the last price of $22.2199993133545.
For Arrowhead Pharmaceuticals stock forecast for 2027, 12 predictions are offered for each month of 2027 with average Arrowhead Pharmaceuticals stock
forecast of $21.14, a high forecast of $22.19, and a low forecast of $20.06.
The average Arrowhead Pharmaceuticals stock forecast 2027 represents a -4.88%
decrease from the last price of $22.2199993133545.
For Arrowhead Pharmaceuticals stock forecast for 2029 (5 year), 12 predictions are offered for each month of 2029 with average Arrowhead Pharmaceuticals stock
forecast of $20.75, a high forecast of $23.9, and a low forecast of $15.87.
The average Arrowhead Pharmaceuticals stock forecast 2029 represents a -6.62%
decrease from the last price of $22.2199993133545.
For Arrowhead Pharmaceuticals stock forecast 2030, 12 predictions are offered for each month of 2030 with average Arrowhead Pharmaceuticals stock
forecast of $29.0, a high forecast of $63.89, and a low forecast of $14.33.
The average Arrowhead Pharmaceuticals stock forecast 2030 represents a 30.53%
increase from the last price of $22.2199993133545.
For Arrowhead Pharmaceuticals stock forecast for 2034 (10 year), 9 predictions are offered for each month of 2034 with average Arrowhead Pharmaceuticals stock
forecast of $26.09, a high forecast of $28.51, and a low forecast of $22.33.
The average Arrowhead Pharmaceuticals stock forecast 2034 represents a 17.4%
increase from the last price of $22.2199993133545.
Please, see more forecasts below.
ARWR : Arrowhead Pharmaceuticals stock forecast by Wall Street Analysts
The average Arrowhead Pharmaceuticals stock forecast from last 6 month is $61.64, and this show a -4.99% decrease in average from the prior price target of the each prediction. Also, this average forecast of $61.64 represents a 38.21% increase from the past average forecast of $44.6, 6 months ago from 10 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2024-09-05 | HC Wainwright & Co. | $60.00 | $60.00 | Buy |
| 2024-09-03 | HC Wainwright & Co. | $60.00 | $60.00 | Buy |
| 2024-08-12 | B. Riley Securities | $55.00 | $55 | Buy |
| 2024-07-23 | HC Wainwright & Co. | $60.00 | $60.00 | Buy |
| 2024-07-17 | Chardan Capital | $60.00 | $60.00 | Buy |
| 2024-07-05 | HC Wainwright & Co. | $90.00 | $60 | Buy |
| 2024-06-26 | Chardan Capital | $60.00 | $60.00 | Buy |
| 2024-06-20 | Cantor Fitzgerald | Overweight | ||
| 2024-06-11 | HC Wainwright & Co. | $90.00 | $90.00 | Buy |
| 2024-06-05 | Goldman Sachs | $31.0000 | Neutral | |
| 2024-06-03 | Chardan Capital | $60.00 | $60.00 | Buy |
| 2024-06-03 | HC Wainwright & Co. | $90.00 | $90.0000 | Buy |
| 2024-05-13 | HC Wainwright & Co. | $90.0000 | Buy | |
| 2024-05-13 | Morgan Stanley | $36.00 | $27 | Equal-Weight |
| 2024-05-10 | Chardan Capital | $60.00 | $60.00 | Buy |
| 2024-02-08 | HC Wainwright & Co. | $90.0000 | Buy | |
| 2024-02-07 | Morgan Stanley | $34.0000 | $36.0000 | Equal-Weight |
| 2024-02-07 | RBC Capital | $50.0000 | Outperform | |
| 2024-02-07 | Citigroup | $33.00 | $34 | Neutral |
| 2024-01-16 | RBC Capital | $50.0000 | Outperform | |
| 2024-01-02 | B of A Securities | $29.00 | $37 | Buy |
| 2023-12-04 | B of A Securities | $29.0000 | Buy | |
| 2023-11-30 | RBC Capital | $50.0000 | Outperform | |
| 2023-11-30 | Morgan Stanley | $40.00 | $37.0000 | Equal-Weight |
| 2023-09-19 | Citigroup | $33.0000 | Neutral |
Arrowhead Pharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2024-09-09 | $21.95 | -1.21% |
| 2024-09-10 | $22.62 | 3.06% |
| 2024-09-11 | $22.38 | -1.06% |
| 2024-09-12 | $22.47 | 0.38% |
| 2024-09-13 | $22.42 | -0.24% |
ARWR : Long term Arrowhead Pharmaceuticals stock forecast for 2024 - 2025 - 2030
Forecast for 2024 Oct. is $22.38 , for 2025 Sep. is $19.29 , for 2028 Sep. is $21.57 , for 2029 Sep. is $19.19 , for 2033 Sep. is $18.86 , and for 2034 Sep. is $23.48.
ARWR : Arrowhead Pharmaceuticals stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Oct. | $22.38 | 0.71% |
| 2024 Nov. | $22.51 | 0.59% |
| 2024 Dec. | $22.38 | -0.57% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $22.22 | -0.71% |
| 2025 Feb. | $21.84 | -1.73% |
| 2025 Mar. | $21.26 | -2.65% |
| 2025 Apr. | $20.74 | -2.42% |
| 2025 May. | $20.27 | -2.26% |
| 2025 Jun. | $19.89 | -1.92% |
| 2025 Jul. | $19.66 | -1.16% |
| 2025 Aug. | $19.44 | -1.11% |
| 2025 Sep. | $19.29 | -0.76% |
| 2025 Oct. | $19.19 | -0.51% |
| 2025 Nov. | $19.21 | 0.11% |
| 2025 Dec. | $19.27 | 0.28% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $19.35 | 0.40% |
| 2026 Feb. | $19.53 | 0.95% |
| 2026 Mar. | $19.74 | 1.10% |
| 2026 Apr. | $20.04 | 1.49% |
| 2026 May. | $20.37 | 1.65% |
| 2026 Jun. | $20.71 | 1.68% |
| 2026 Jul. | $21.05 | 1.65% |
| 2026 Aug. | $21.38 | 1.55% |
| 2026 Sep. | $21.68 | 1.41% |
| 2026 Oct. | $21.90 | 1.03% |
| 2026 Nov. | $22.08 | 0.78% |
| 2026 Dec. | $22.18 | 0.46% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $22.19 | 0.04% |
| 2027 Feb. | $22.11 | -0.35% |
| 2027 Mar. | $21.96 | -0.68% |
| 2027 Apr. | $21.74 | -1.01% |
| 2027 May. | $21.50 | -1.09% |
| 2027 Jun. | $21.26 | -1.11% |
| 2027 Jul. | $21.00 | -1.22% |
| 2027 Aug. | $20.76 | -1.14% |
| 2027 Sep. | $20.54 | -1.06% |
| 2027 Oct. | $20.35 | -0.91% |
| 2027 Nov. | $20.19 | -0.78% |
| 2027 Dec. | $20.06 | -0.65% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $19.96 | -0.50% |
| 2028 Feb. | $19.89 | -0.34% |
| 2028 Mar. | $19.86 | -0.14% |
| 2028 Apr. | $19.89 | 0.15% |
| 2028 May. | $19.99 | 0.46% |
| 2028 Jun. | $20.17 | 0.92% |
| 2028 Jul. | $20.48 | 1.52% |
| 2028 Aug. | $20.94 | 2.26% |
| 2028 Sep. | $21.57 | 3.00% |
| 2028 Oct. | $22.32 | 3.50% |
| 2028 Nov. | $23.08 | 3.41% |
| 2028 Dec. | $23.66 | 2.52% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $23.90 | 1.02% |
| 2029 Feb. | $23.77 | -0.57% |
| 2029 Mar. | $23.34 | -1.78% |
| 2029 Apr. | $22.82 | -2.24% |
| 2029 May. | $22.29 | -2.32% |
| 2029 Jun. | $21.68 | -2.74% |
| 2029 Jul. | $20.97 | -3.26% |
| 2029 Aug. | $20.17 | -3.81% |
| 2029 Sep. | $19.19 | -4.86% |
| 2029 Oct. | $18.06 | -5.89% |
| 2029 Nov. | $16.91 | -6.37% |
| 2029 Dec. | $15.87 | -6.18% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $15.02 | -5.34% |
| 2030 Feb. | $14.47 | -3.63% |
| 2030 Mar. | $14.33 | -1.03% |
| 2030 Apr. | $14.63 | 2.16% |
| 2030 May. | $15.52 | 6.06% |
| 2030 Jun. | $17.36 | 11.84% |
| 2030 Jul. | $21.01 | 21.03% |
| 2030 Aug. | $27.69 | 31.79% |
| 2030 Sep. | $37.97 | 37.13% |
| 2030 Oct. | $49.27 | 29.78% |
| 2030 Nov. | $56.90 | 15.47% |
| 2030 Dec. | $63.89 | 12.30% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $79.75 | 24.81% |
| 2031 Feb. | $90.78 | 13.83% |
| 2031 Mar. | $96.11 | 5.88% |
| 2031 Apr. | $102.13 | 6.26% |
| 2031 May. | $107.70 | 5.45% |
| 2031 Jun. | $112.22 | 4.19% |
| 2031 Jul. | $116.23 | 3.58% |
| 2031 Aug. | $119.62 | 2.91% |
| 2031 Sep. | $120.84 | 1.02% |
| 2031 Oct. | $119.32 | -1.26% |
| 2031 Nov. | $115.72 | -3.02% |
| 2031 Dec. | $110.82 | -4.23% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $105.16 | -5.11% |
| 2032 Feb. | $99.47 | -5.41% |
| 2032 Mar. | $94.93 | -4.57% |
| 2032 Apr. | $89.21 | -6.02% |
| 2032 May. | $81.92 | -8.17% |
| 2032 Jun. | $74.26 | -9.34% |
| 2032 Jul. | $66.78 | -10.08% |
| 2032 Aug. | $59.78 | -10.49% |
| 2032 Sep. | $53.51 | -10.47% |
| 2032 Oct. | $48.20 | -9.92% |
| 2032 Nov. | $43.93 | -8.87% |
| 2032 Dec. | $40.63 | -7.51% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $38.03 | -6.41% |
| 2033 Feb. | $35.63 | -6.30% |
| 2033 Mar. | $32.76 | -8.04% |
| 2033 Apr. | $29.61 | -9.63% |
| 2033 May. | $27.04 | -8.69% |
| 2033 Jun. | $24.68 | -8.73% |
| 2033 Jul. | $22.36 | -9.40% |
| 2033 Aug. | $20.29 | -9.22% |
| 2033 Sep. | $18.86 | -7.06% |
| 2033 Oct. | $18.36 | -2.65% |
| 2033 Nov. | $18.94 | 3.17% |
| 2033 Dec. | $20.31 | 7.21% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $22.33 | 9.97% |
| 2034 Feb. | $24.67 | 10.46% |
| 2034 Mar. | $26.62 | 7.90% |
| 2034 Apr. | $27.92 | 4.90% |
| 2034 May. | $28.51 | 2.13% |
| 2034 Jun. | $28.31 | -0.72% |
| 2034 Jul. | $27.31 | -3.53% |
| 2034 Aug. | $25.63 | -6.13% |
| 2034 Sep. | $23.48 | -8.39% |
Frequently Asked Questions about Arrowhead Pharmaceuticals stock forecast
Is Arrowhead Pharmaceuticals a good long term stock?
From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock can be a good investment choice. According to AIPickup, the Arrowhead Pharmaceuticals stock price forecast for 2024 Oct. is $22.3772979604176 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to AIPickup, the Arrowhead Pharmaceuticals stock price forecast for 2025 Sep. is $19.2907293245527 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to AIPickup, the Arrowhead Pharmaceuticals stock price forecast for 2028 Sep. is $21.5653427327987 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to AIPickup, the Arrowhead Pharmaceuticals stock price forecast for 2029 Sep. is $19.1934842820913 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to AIPickup, the Arrowhead Pharmaceuticals stock price forecast for 2033 Sep. is $18.85994690387 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock can be a good investment choice. According to AIPickup, the Arrowhead Pharmaceuticals stock price forecast for 2034 Sep. is $23.4833121231014
Is Arrowhead Pharmaceuticals stock overvalued?
Arrowhead Pharmaceuticals (ARWR) stock is expected to go DOWN . Therefore, AIPickup would say that Arrowhead Pharmaceuticals (ARWR) stock is overvalued.
Will Arrowhead Pharmaceuticals stock price go up?
No. The Arrowhead Pharmaceuticals stock price forecast for 2025 Sep. is $19.2907293245527
Is Arrowhead Pharmaceuticals stock a good buy now?
Since closing price on 2024-09-06 is $22.2199993133545 and forecast for 2025 Sep. is $19.29, Arrowhead Pharmaceuticals stock is not a good 1 year investment.
14 Days Historical Data for Arrowhead Pharmaceuticals stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| ARWR stock price for 2024-08-19 | $23.35 | $22.68 | $22.67 | $23.40 |
| ARWR stock price for 2024-08-20 | $23.60 | $23.21 | $22.97 | $23.77 |
| ARWR stock price for 2024-08-21 | $25.24 | $23.67 | $23.67 | $25.37 |
| ARWR stock price for 2024-08-22 | $24.37 | $25.24 | $24.16 | $25.38 |
| ARWR stock price for 2024-08-23 | $24.78 | $24.68 | $24.33 | $25.09 |
| ARWR stock price for 2024-08-26 | $24.70 | $24.86 | $24.54 | $25.14 |
| ARWR stock price for 2024-08-27 | $23.94 | $24.43 | $23.45 | $24.65 |
| ARWR stock price for 2024-08-28 | $23.93 | $23.95 | $23.47 | $24.19 |
| ARWR stock price for 2024-08-29 | $24.08 | $24.24 | $23.96 | $24.67 |
| ARWR stock price for 2024-08-30 | $23.83 | $24.12 | $23.24 | $24.28 |
| ARWR stock price for 2024-09-03 | $22.91 | $24.02 | $22.82 | $24.77 |
| ARWR stock price for 2024-09-04 | $23.98 | $22.70 | $22.65 | $24.09 |
| ARWR stock price for 2024-09-05 | $23.25 | $24.20 | $23.07 | $24.20 |
| ARWR stock price for 2024-09-06 | $22.22 | $23.25 | $21.98 | $23.44 |